OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,993	7,100	15,388	15,910	15,831	22,680
Market Cap Growth	-66.80%	-53.86%	-3.28%	0.50%	-30.20%	-13.48%
Enterprise Value	5,159	6,951	15,559	14,396	12,411	21,039
Last Close Price	37.95	54.00	117.00	137.98	137.38	224.38
PS Ratio	85.25	121.22	245.51	382.92	3360.52	1208.19
PB Ratio	1.83	2.61	3.19	3.21	2.58	5.86
P/TBV Ratio	2.71	3.86	4.10	4.26	3.73	9.79
EV/Sales Ratio	88.08	118.67	248.24	346.49	2634.54	1120.77
Debt / Equity Ratio	0.19	0.19	0.11	0.11	0.05	0.08
Net Debt / Equity Ratio	-0.25	-0.25	-0.55	-0.45	-0.73	-0.61
Net Debt / EBITDA Ratio	0.34	0.34	1.19	1.17	2.32	1.52
Net Debt / FCF Ratio	0.33	0.33	1.35	1.27	2.39	1.81
Asset Turnover	0.01	0.01	0.01	0.01	0.00	0.00
Inventory Turnover	5.90	5.90	5.18	4.80	2.85	5.24
Quick Ratio	4.30	4.30	8.20	18.18	21.71	8.18
Current Ratio	4.51	4.51	8.34	19.10	22.76	8.72
Return on Equity (ROE)	-59.82%	-59.82%	-51.01%	-22.83%	-37.96%	-39.45%
Return on Assets (ROA)	-29.87%	-29.87%	-26.32%	-21.33%	-23.86%	-21.83%
Return on Capital Employed (ROCE)	-70.60%	-70.60%	-45.20%	-38.40%	-33.10%	-41.30%
Earnings Yield	-41.11%	-28.91%	-15.01%	-6.58%	-10.19%	-6.75%
FCF Yield	-41.33%	-29.07%	-12.65%	-11.03%	-11.84%	-5.76%
Buyback Yield / Dilution	-12.56%	-12.56%	-1.99%	-3.12%	-11.65%	-0.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.